ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
The paper provides the clinical characteristics of etoricoxib (Arcoxia), a new selective cyclooxygenase-2 inhibitor having unique properties, which permits it to be distinguished among other nonsteroidal anti-inflammatory agents.
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
IMA-PRESS LLC
2009-06-01
|
| Schriftenreihe: | Современная ревматология |
| Schlagworte: | |
| Online-Zugang: | https://mrj.ima-press.net/mrj/article/view/229 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|